Boloc, Daniel
Gortat, Anna
Cheng-Zhang, Jia Qi
García-Cerro, Susana
Rodríguez, Natalia
Parellada, Mara
Saiz-Ruiz, Jeronimo
Cuesta, Manolo J.
Gassó, Patricia
Lafuente, Amalia
Bernardo, Miquel
Mas, Sergi http://orcid.org/0000-0003-3336-6298
Article History
Received: 22 May 2018
Revised: 15 October 2018
Accepted: 13 November 2018
First Online: 13 December 2018
Change Date: 2 May 2019
Change Type: Correction
Change Details: One of the funding sources (FEDER-Unión Europea) was not previously acknowledged in this Article. This study was supported by the Spanish Ministry of Health, Instituto de Salud Carlos III (FIS, Fondo de Investigacion Sanitaria PI13/00812, PI16/0122) and FEDER-Unión Europea.
Conflict of interest
: J.S.-R. has been a speaker for and on the advisory boards of Lilly, GlaxoSmithKline, Lundbeck, Janssen, Servier, and Pfizer and has received grant/honoraria from Lilly and Astra-Zeneca. M.B. has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory board of ABBiotics, Adamed, Almirall, AMGEN, Boehringer, Eli Lilly, Ferrer, Forum Pharmaceuticals, Gedeon, Hersill, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Roche and Servier. The other authors declare no conflict of interests.